# Endothelial Function and Autonomic Regulation After Short-term Smoking Cessation: Varenicline Versus Placebo

> **NCT00673595** · NA · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 19 (actual)

## Conditions studied

- Smoking

## Interventions

- **DRUG:** Varenicline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00673595
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-03
- **Primary completion:** 2009-02
- **Final completion:** 2010-02
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Difficulty with recruiting sujects and subjects complying with the protocol
- **Last updated:** 2012-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00673595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00673595, "Endothelial Function and Autonomic Regulation After Short-term Smoking Cessation: Varenicline Versus Placebo". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00673595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*